Sitagliptin Hydrochloride Hydrate is an oral antihyperglycemic agent belonging to the dipeptidyl peptidase-4 (DPP-4) inhibitor class, indicated for the management of type 2 diabetes mellitus. By inhibiting… Read more
Sitagliptin Hydrochloride Hydrate is an oral antihyperglycemic agent belonging to the dipeptidyl peptidase-4 (DPP-4) inhibitor class, indicated for the management of type 2 diabetes mellitus. By inhibiting the DPP-4 enzyme, this compound slows the inactivation of incretin hormones, thereby enhancing insulin secretion and suppressing glucagon release to improve glycemic control. For the pharmaceutical development and regulatory oversight of this active ingredient, precise analytical standards are required. This category contains reference standards for Sitagliptin Hydrochloride Hydrate, including its associated organic impurities, metabolites, and stable isotope-labelled compounds. These materials are essential for pharmaceutical laboratories performing impurity profiling, method validation, and quality control routines. By providing consistent standards, they enable accurate quantitation and identification, helping to ensure product purity and compliance with rigorous international safety and quality standards during analytical testing.